Andover, MA, United States of America

James Carl Keith, Jr

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Emstopa Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Carl Keith, Jr. Retrieved from https://idiyas.com/inventor/james-carl-keith-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Carl Keith, Jr: Innovator in Medical Science

Introduction

James Carl Keith, Jr. is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of medical science, particularly through his innovative work on tissue plasminogen activator antibodies.

Latest Patents

James holds a patent for "Tissue Plasminogen Activator Antibodies and Method of Use Thereof." This patent represents his commitment to advancing medical treatments and improving patient outcomes. He has 1 patent to his name.

Career Highlights

James is currently associated with Emstopa Limited, where he continues to develop and refine his innovative ideas. His work at the company focuses on creating solutions that can have a profound impact on healthcare.

Collaborations

James collaborates with talented individuals such as Alexander Noel Fraser Brown and Preeti Bakrania. These partnerships enhance his research and development efforts, leading to more effective innovations.

Conclusion

James Carl Keith, Jr. exemplifies the spirit of innovation in the medical field. His contributions through patents and collaborations are paving the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…